Early change in glucose metabolic rate measured using FDG-PET in patients with high-grade glioma predicts response to temozolomide but not temozolomide plus radiotherapy

Natalie Charnley, Catharine M. West, Carolyn M. Barnett, Catherine Brock, Graeme M. Bydder, Mark Glaser, Ed S. Newlands, Ric Swindell, Julian Matthews, Pat Price

    Research output: Contribution to journal › Article › peer-review

    Fingerprint

    Dive into the research topics of 'Early change in glucose metabolic rate measured using FDG-PET in patients with high-grade glioma predicts response to temozolomide but not temozolomide plus radiotherapy'. Together they form a unique fingerprint.

    Medicine and Dentistry

    Neuroscience